<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35336898</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Viral Infection and Respiratory Exacerbation in Children: Results from a Local German Pediatric Exacerbation Cohort.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">491</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14030491</ELocationID><Abstract><AbstractText>Respiratory viruses play an important role in asthma exacerbation, and early exposure can be involved in recurrent bronchitis and the development of asthma. The exact mechanism is not fully clarified, and pathogen-to-host interaction studies are warranted to identify biomarkers of exacerbation in the early phase. Only a limited number of international exacerbation cohorts were studied. Here, we have established a local pediatric exacerbation study in Germany consisting of children with asthma or chronic, recurrent bronchitis and analyzed the viriome within the nasopharyngeal swab specimens derived from the entire cohort (<i>n</i> = 141). Interestingly, 41% of exacerbated children had a positive test result for human rhinovirus (HRV)/human enterovirus (HEV), and 14% were positive for respiratory syncytial virus (RSV). HRV was particularly prevalent in asthmatics (56%), wheezers (50%), and atopic (66%) patients. Lymphocytes were decreased in asthmatics and in HRV-infected subjects, and patients allergic to house dust mites were more susceptible to HRV infection. Our study thus confirms HRV infection as a strong 'biomarker' of exacerbated asthma. Further longitudinal studies will show the clinical progress of those children with a history of an RSV or HRV infection. Vaccination strategies and novel treatment guidelines against HRV are urgently needed to protect those high-risk children from a serious course of disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sallard</LastName><ForeName>Erwan</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2324-3633</Identifier><AffiliationInfo><Affiliation>Center for Biomedical Education and Research (ZBAF), Department of Human Medicine, Faculty of Health, Institute of Virology and Microbiology, Witten/Herdecke University, 58453 Witten, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schult</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Child and Adolescent Medicine, Center for Clinical and Translational Research (CCTR), Helios University Hospital Wuppertal, Witten/Herdecke University, 42283 Wuppertal, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baehren</LastName><ForeName>Carolin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Pediatric Pneumology and Allergology, Center for Biomedical Education and Research, Faculty of Health, School of Life Sciences (ZBAF), Witten/Herdecke University, 58455 Witten, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buedding</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Experimental Pediatric Pneumology and Allergology, Center for Biomedical Education and Research, Faculty of Health, School of Life Sciences (ZBAF), Witten/Herdecke University, 58455 Witten, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mboma</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Center for Child and Adolescent Medicine, Center for Clinical and Translational Research (CCTR), Helios University Hospital Wuppertal, Witten/Herdecke University, 42283 Wuppertal, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad-Nejad</LastName><ForeName>Parviz</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute for Medical Laboratory Diagnostics, Center for Clinical and Translational Research (CCTR), Helios University Hospital Wuppertal, Witten/Herdecke University, 42283 Wuppertal, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghebremedhin</LastName><ForeName>Beniam</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7640-0375</Identifier><AffiliationInfo><Affiliation>Institute for Medical Laboratory Diagnostics, Center for Clinical and Translational Research (CCTR), Helios University Hospital Wuppertal, Witten/Herdecke University, 42283 Wuppertal, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehrhardt</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Biomedical Education and Research (ZBAF), Department of Human Medicine, Faculty of Health, Institute of Virology and Microbiology, Witten/Herdecke University, 58453 Witten, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wirth</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Child and Adolescent Medicine, Center for Clinical and Translational Research (CCTR), Helios University Hospital Wuppertal, Witten/Herdecke University, 42283 Wuppertal, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydin</LastName><ForeName>Malik</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Child and Adolescent Medicine, Center for Clinical and Translational Research (CCTR), Helios University Hospital Wuppertal, Witten/Herdecke University, 42283 Wuppertal, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Experimental Pediatric Pneumology and Allergology, Center for Biomedical Education and Research, Faculty of Health, School of Life Sciences (ZBAF), Witten/Herdecke University, 58455 Witten, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001991" MajorTopicYN="Y">Bronchitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="Y">Respiratory Syncytial Virus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">bronchitis</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">exacerbation</Keyword><Keyword MajorTopicYN="N">human rhinovirus</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">respiratory syncytial virus</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35336898</ArticleId><ArticleId IdType="pmc">PMC8955305</ArticleId><ArticleId IdType="doi">10.3390/v14030491</ArticleId><ArticleId IdType="pii">v14030491</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ntontsi P., Photiades A., Zervas E., Xanthou G., Samitas K. Genetics and Epigenetics in Asthma. Int. J. Mol. Sci. 2021;22:2412. doi: 10.3390/ijms22052412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052412</ArticleId><ArticleId IdType="pmc">PMC7957649</ArticleId><ArticleId IdType="pubmed">33673725</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., Aboyans V., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–2196. doi: 10.1016/S0140-6736(12)61729-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61729-2</ArticleId><ArticleId IdType="pmc">PMC6350784</ArticleId><ArticleId IdType="pubmed">23245607</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallol J., Crane J., von Mutius E., Odhiambo J., Keil U., Stewart A., Group I.P.T.S. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesis. Allergol. Immunopathol. 2013;41:73–85. doi: 10.1016/j.aller.2012.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aller.2012.03.001</ArticleId><ArticleId IdType="pubmed">22771150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearce N., Ait-Khaled N., Beasley R., Mallol J., Keil U., Mitchell E., Robertson C., Group I.P.T.S. Worldwide trends in the prevalence of asthma symptoms: Phase III of the International Study of Asthma and Allergies in Childhood (ISAAC) Thorax. 2007;62:758–766. doi: 10.1136/thx.2006.070169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2006.070169</ArticleId><ArticleId IdType="pmc">PMC2117323</ArticleId><ArticleId IdType="pubmed">17504817</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmage S.C., Perret J.L., Custovic A. Epidemiology of Asthma in Children and Adults. Front. Pediatr. 2019;7:246. doi: 10.3389/fped.2019.00246.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00246</ArticleId><ArticleId IdType="pmc">PMC6591438</ArticleId><ArticleId IdType="pubmed">31275909</ArticleId></ArticleIdList></Reference><Reference><Citation>Diseases G.B.D., Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–1222. doi: 10.1016/S0140-6736(20)30925-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30925-9</ArticleId><ArticleId IdType="pmc">PMC7567026</ArticleId><ArticleId IdType="pubmed">33069326</ArticleId></ArticleIdList></Reference><Reference><Citation>The Global Asthma Report 2018. Global Asthma Network; Auckland, New Zealand: 2018.</Citation></Reference><Reference><Citation>Akmatov M.K., Holstiege J., Steffen A., Batzing J. Trends and regional distribution of outpatient claims for asthma, 2009-2016, Germany. Bull. World Health Organ. 2020;98:40–51. doi: 10.2471/BLT.19.229773.</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.19.229773</ArticleId><ArticleId IdType="pmc">PMC6933432</ArticleId><ArticleId IdType="pubmed">31902961</ArticleId></ArticleIdList></Reference><Reference><Citation>Backer V., Harmsen L., Lund T., Pedersen L., Porsbjerg C., Rasmussen L., Thomsen S.F., Nolte H. A 3-year longitudinal study of asthma quality of life in undiagnosed and diagnosed asthma patients. Int. J. Tuberc. Lung Dis. 2007;11:463–469.</Citation><ArticleIdList><ArticleId IdType="pubmed">17394695</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marco R., Cerveri I., Bugiani M., Ferrari M., Verlato G. An undetected burden of asthma in Italy: The relationship between clinical and epidemiological diagnosis of asthma. Eur. Respir. J. 1998;11:599–605.</Citation><ArticleIdList><ArticleId IdType="pubmed">9596109</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Gent R., van Essen L.E., Rovers M.M., Kimpen J.L., van der Ent C.K., de Meer G. Quality of life in children with undiagnosed and diagnosed asthma. Eur. J. Pediatr. 2007;166:843–848. doi: 10.1007/s00431-006-0358-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-006-0358-y</ArticleId><ArticleId IdType="pubmed">17589815</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu A.C., Greenberger P.A. Asthma: Overdiagnosed, Underdiagnosed, and Ineffectively Treated. J. Allergy Clin. Immunol. Pract. 2018;6:801–802. doi: 10.1016/j.jaip.2018.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2018.02.023</ArticleId><ArticleId IdType="pmc">PMC7038386</ArticleId><ArticleId IdType="pubmed">29747983</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesärztekammer (BÄK) Kassenärztliche Bundesvereinigung (KBV) Arbeitsgemein-schaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Asthma—Langfassung. Auflage. 2020;4 doi: 10.6101/AZQ/000469.</Citation><ArticleIdList><ArticleId IdType="doi">10.6101/AZQ/000469</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbank A.J., Sood A.K., Kesic M.J., Peden D.B., Hernandez M.L. Environmental determinants of allergy and asthma in early life. J. Allergy Clin. Immunol. 2017;140:1–12. doi: 10.1016/j.jaci.2017.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.05.010</ArticleId><ArticleId IdType="pmc">PMC5675123</ArticleId><ArticleId IdType="pubmed">28673399</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez L., Declercq C., Iniguez C., Aguilera I., Badaloni C., Ballester F., Bouland C., Chanel O., Cirarda F.B., Forastiere F., et al. Chronic burden of near-roadway traffic pollution in 10 European cities (APHEKOM network) Eur. Respir. J. 2013;42:594–605. doi: 10.1183/09031936.00031112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00031112</ArticleId><ArticleId IdType="pubmed">23520318</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse W.W., Lemanske R.F., Jr., Gern J.E. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376:826–834. doi: 10.1016/S0140-6736(10)61380-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61380-3</ArticleId><ArticleId IdType="pmc">PMC2972660</ArticleId><ArticleId IdType="pubmed">20816549</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T., Gern J.E. Role of viral infections in the development and exacerbation of asthma in children. J. Allergy Clin. Immunol. 2017;140:895–906. doi: 10.1016/j.jaci.2017.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.08.003</ArticleId><ArticleId IdType="pmc">PMC7172811</ArticleId><ArticleId IdType="pubmed">28987219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko F.W., Chan P.K., Chan R.W.Y., Chan K.P., Ip A., Kwok A., Ngai J.C., Ng S.S., On C.T., Hui D.S. Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease. Respir. Res. 2019;20:210. doi: 10.1186/s12931-019-1181-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1181-0</ArticleId><ArticleId IdType="pmc">PMC6743175</ArticleId><ArticleId IdType="pubmed">31519188</ArticleId></ArticleIdList></Reference><Reference><Citation>Merckx J., Ducharme F.M., Martineau C., Zemek R., Gravel J., Chalut D., Poonai N., Quach C., Pediatric Emergency Research Canada D.T. Respiratory Viruses and Treatment Failure in Children with Asthma Exacerbation. Pediatrics. 2018;142 doi: 10.1542/peds.2017-4105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2017-4105</ArticleId><ArticleId IdType="pubmed">29866794</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S.Y., Wang L.L., Ren L., Luo J., Liao W., Liu E.M. Epidemiological analysis and follow-up of human rhinovirus infection in children with asthma exacerbation. J. Med. Virol. 2018;90:219–228. doi: 10.1002/jmv.24850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24850</ArticleId><ArticleId IdType="pmc">PMC7167043</ArticleId><ArticleId IdType="pubmed">28500687</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchers A.T., Chang C., Gershwin M.E., Gershwin L.J. Respiratory syncytial virus—A comprehensive review. Clin. Rev. Allergy Immunol. 2013;45:331–379. doi: 10.1007/s12016-013-8368-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-013-8368-9</ArticleId><ArticleId IdType="pmc">PMC7090643</ArticleId><ArticleId IdType="pubmed">23575961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatziparasidis G., Kantar A. COVID-19 in Children with Asthma. Lung. 2021;199:7–12. doi: 10.1007/s00408-021-00419-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00419-9</ArticleId><ArticleId IdType="pmc">PMC7835665</ArticleId><ArticleId IdType="pubmed">33496842</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow E.J., Doyle J.D., Uyeki T.M. Influenza virus-related critical illness: Prevention, diagnosis, treatment. Crit. Care. 2019;23:214. doi: 10.1186/s13054-019-2491-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2491-9</ArticleId><ArticleId IdType="pmc">PMC6563376</ArticleId><ArticleId IdType="pubmed">31189475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar K., Singanayagam A., Johnston S.L. Respiratory Virus Infections in Asthma: Research Developments and Therapeutic Advances. Acta. Med. Acad. 2020;49:130–143. doi: 10.5644/ama2006-124.292.</Citation><ArticleIdList><ArticleId IdType="doi">10.5644/ama2006-124.292</ArticleId><ArticleId IdType="pubmed">33189119</ArticleId></ArticleIdList></Reference><Reference><Citation>Obuchi M., Adachi Y., Takizawa T., Sata T. Influenza A(H1N1)pdm09 virus and asthma. Front. Microbiol. 2013;4:307. doi: 10.3389/fmicb.2013.00307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2013.00307</ArticleId><ArticleId IdType="pmc">PMC3796256</ArticleId><ArticleId IdType="pubmed">24133489</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U., Ding M., Tan G., Zhakparov D., Peng Y., Wawrzyniak P., Wang M., Li S., Morita H., Altunbulakli C., et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75:2829–2845. doi: 10.1111/all.14429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14429</ArticleId><ArticleId IdType="pmc">PMC7300910</ArticleId><ArticleId IdType="pubmed">32496587</ArticleId></ArticleIdList></Reference><Reference><Citation>Sienko J., Kotowski M., Bogacz A., Lechowicz K., Drozdzal S., Rosik J., Sietnicki M., Sienko M., Kotfis K. COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients. Clin. Interv. Aging. 2020;15:1231–1240. doi: 10.2147/CIA.S261516.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S261516</ArticleId><ArticleId IdType="pmc">PMC7382582</ArticleId><ArticleId IdType="pubmed">32764907</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay H., Wark P.A., Bartlett N.W. Advances in the treatment of virus-induced asthma. Expert Rev. Respir. Med. 2016;10:629–641. doi: 10.1080/17476348.2016.1180249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2016.1180249</ArticleId><ArticleId IdType="pmc">PMC7103718</ArticleId><ArticleId IdType="pubmed">27088397</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipriani F., Calamelli E., Ricci G. Allergen Avoidance in Allergic Asthma. Front. Pediatr. 2017;5:103. doi: 10.3389/fped.2017.00103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2017.00103</ArticleId><ArticleId IdType="pmc">PMC5423906</ArticleId><ArticleId IdType="pubmed">28540285</ArticleId></ArticleIdList></Reference><Reference><Citation>Guibas G.V., Mathioudakis A.G., Tsoumani M., Tsabouri S. Relationship of Allergy with Asthma: There Are More Than the Allergy "Eggs" in the Asthma ”Basket”. Front. Pediatr. 2017;5:92. doi: 10.3389/fped.2017.00092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2017.00092</ArticleId><ArticleId IdType="pmc">PMC5408007</ArticleId><ArticleId IdType="pubmed">28503545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashmi M.F., Tariq M., Cataletto M.E. StatPearls. StatPearls; Treasure Island, FL, USA: 2022. Asthma.</Citation></Reference><Reference><Citation>Locksley R.M. Asthma and allergic inflammation. Cell. 2010;140:777–783. doi: 10.1016/j.cell.2010.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.03.004</ArticleId><ArticleId IdType="pmc">PMC3134388</ArticleId><ArticleId IdType="pubmed">20303868</ArticleId></ArticleIdList></Reference><Reference><Citation>Quirt J., Hildebrand K.J., Mazza J., Noya F., Kim H. Asthma. Allergy Asthma Clin. Immunol. 2018;14:50. doi: 10.1186/s13223-018-0279-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13223-018-0279-0</ArticleId><ArticleId IdType="pmc">PMC6157154</ArticleId><ArticleId IdType="pubmed">30275843</ArticleId></ArticleIdList></Reference><Reference><Citation>Finotto S. Resolution of allergic asthma. Semin Immunopathol. 2019;41:665–674. doi: 10.1007/s00281-019-00770-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-019-00770-3</ArticleId><ArticleId IdType="pubmed">31705318</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesch F., Sydendal Grand T., Wuestenberg E., Elliott L., Schmitt J., Kuster D. Healthcare costs associated with allergic rhinitis, asthma allergy immunotherapy. Eur Ann. Allergy Clin. Immunol. 2020;52:164–174. doi: 10.23822/EurAnnACI.1764-1489.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.23822/EurAnnACI.1764-1489.126</ArticleId><ArticleId IdType="pubmed">31818082</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu J., Qin X., Beavers S.F., Mirabelli M.C. Asthma-Related School Absenteeism, Morbidity, and Modifiable Factors. Am. J. Prev. Med. 2016;51:23–32. doi: 10.1016/j.amepre.2015.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2015.12.012</ArticleId><ArticleId IdType="pmc">PMC4914465</ArticleId><ArticleId IdType="pubmed">26873793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergroth E., Aakula M., Elenius V., Remes S., Piippo-Savolainen E., Korppi M., Piedra P.A., Bochkov Y.A., Gern J.E., Camargo C.A., Jr., et al. Rhinovirus Type in Severe Bronchiolitis and the Development of Asthma. J. Allergy Clin. Immunol. Pract. 2020;8:588–595.e584. doi: 10.1016/j.jaip.2019.08.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2019.08.043</ArticleId><ArticleId IdType="pmc">PMC7012669</ArticleId><ArticleId IdType="pubmed">31520837</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Pan Y., Zhu Y., Song Y., Su X., Yang L., Li M. Association between rhinovirus wheezing illness and the development of childhood asthma: A meta-analysis. BMJ Open. 2017;7:e013034. doi: 10.1136/bmjopen-2016-013034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-013034</ArticleId><ArticleId IdType="pmc">PMC5387933</ArticleId><ArticleId IdType="pubmed">28373249</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehling L.M., Heymann P.W., Wright P.W., Eccles J.D., Agrawal R., Carper H.T., Murphy D.D., Workman L.J., Word C.R., Ratcliffe S.J., et al. Human TH1 and TH2 cells targeting rhinovirus and allergen coordinately promote allergic asthma. J. Allergy Clin. Immunol. 2020;146:555–570. doi: 10.1016/j.jaci.2020.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7483727</ArticleId><ArticleId IdType="pubmed">32320734</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams T.C., Jackson D.J., Maltby S., Walton R.P., Ching Y.M., Glanville N., Singanayagam A., Brewins J.J., Clarke D., Hirsman A.G., et al. Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6. Am. J. Respir Cell Mol. Biol. 2021;64:344–356. doi: 10.1165/rcmb.2020-0011OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2020-0011OC</ArticleId><ArticleId IdType="pmc">PMC7909342</ArticleId><ArticleId IdType="pubmed">33264064</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutts J., Fullarton J., Morris C., Grubb E., Buchan S., Rodgers-Gray B., Thwaites R. Association between respiratory syncytial virus hospitalization in infancy and childhood asthma. Pediatr. Pulmonol. 2020;55:1104–1110. doi: 10.1002/ppul.24676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.24676</ArticleId><ArticleId IdType="pmc">PMC7187471</ArticleId><ArticleId IdType="pubmed">32040885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruotsalainen M., Hyvarinen M.K., Piippo-Savolainen E., Korppi M. Adolescent asthma after rhinovirus and respiratory syncytial virus bronchiolitis. Pediatr. Pulmonol. 2013;48:633–639. doi: 10.1002/ppul.22692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.22692</ArticleId><ArticleId IdType="pubmed">23129516</ArticleId></ArticleIdList></Reference><Reference><Citation>Coverstone A.M., Wang L., Sumino K. Beyond Respiratory Syncytial Virus and Rhinovirus in the Pathogenesis and Exacerbation of Asthma: The Role of Metapneumovirus, Bocavirus and Influenza Virus. Immunol. Allergy Clin. N. Am. 2019;39:391–401. doi: 10.1016/j.iac.2019.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2019.03.007</ArticleId><ArticleId IdType="pmc">PMC7127190</ArticleId><ArticleId IdType="pubmed">31284928</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Garcia M.L., Calvo Rey C., Del Rosal Rabes T. Pediatric Asthma and Viral Infection. Arch. Bronconeumol. 2016;52:269–273. doi: 10.1016/j.arbres.2015.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbres.2015.11.008</ArticleId><ArticleId IdType="pmc">PMC7105201</ArticleId><ArticleId IdType="pubmed">26766408</ArticleId></ArticleIdList></Reference><Reference><Citation>Jartti T., Bonnelykke K., Elenius V., Feleszko W. Role of viruses in asthma. Semin. Immunopathol. 2020;42:61–74. doi: 10.1007/s00281-020-00781-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-020-00781-5</ArticleId><ArticleId IdType="pmc">PMC7066101</ArticleId><ArticleId IdType="pubmed">31989228</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilbert T.W., Singh A.M., Danov Z., Evans M.D., Jackson D.J., Burton R., Roberg K.A., Anderson E.L., Pappas T.E., Gangnon R., et al. Decreased lung function after preschool wheezing rhinovirus illnesses in children at risk to develop asthma. J. Allergy Clin. Immunol. 2011;128:532–538.e10. doi: 10.1016/j.jaci.2011.06.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2011.06.037</ArticleId><ArticleId IdType="pmc">PMC3233203</ArticleId><ArticleId IdType="pubmed">21878241</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson D.J., Gangnon R.E., Evans M.D., Roberg K.A., Anderson E.L., Pappas T.E., Printz M.C., Lee W.M., Shult P.A., Reisdorf E., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am. J. Respir. Crit. Care Med. 2008;178:667–672. doi: 10.1164/rccm.200802-309OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200802-309OC</ArticleId><ArticleId IdType="pmc">PMC2556448</ArticleId><ArticleId IdType="pubmed">18565953</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubner F.J., Jackson D.J., Evans M.D., Gangnon R.E., Tisler C.J., Pappas T.E., Gern J.E., Lemanske R.F., Jr. Early life rhinovirus wheezing, allergic sensitization, and asthma risk at adolescence. J. Allergy Clin. Immunol. 2017;139:501–507. doi: 10.1016/j.jaci.2016.03.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.03.049</ArticleId><ArticleId IdType="pmc">PMC5104680</ArticleId><ArticleId IdType="pubmed">27312820</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigurs N., Bjarnason R., Sigurbergsson F., Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 2000;161:1501–1507. doi: 10.1164/ajrccm.161.5.9906076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.161.5.9906076</ArticleId><ArticleId IdType="pubmed">10806145</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigurs N., Bjarnason R., Sigurbergsson F., Kjellman B., Bjorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls. Pediatrics. 1995;95:500–505. doi: 10.1542/peds.95.4.500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.95.4.500</ArticleId><ArticleId IdType="pubmed">7700748</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F., Kjellman B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 2005;171:137–141. doi: 10.1164/rccm.200406-730OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200406-730OC</ArticleId><ArticleId IdType="pubmed">15516534</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydin M., Naumova E.A., Lutz S., Meyer-Bahlburg A., Arnold W.H., Kreppel F., Ehrhardt A., Postberg J., Wirth S. Do Current Asthma-Preventive Measures Appropriately Face the World Health Organization’s Concerns: A Study Presentation of a New Clinical, Prospective, Multicentric Pediatric Asthma Exacerbation Cohort in Germany. Front. Pediatr. 2020;8:574462. doi: 10.3389/fped.2020.574462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.574462</ArticleId><ArticleId IdType="pmc">PMC7724104</ArticleId><ArticleId IdType="pubmed">33324591</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelkes M., Baan E.J., de Ridder M.A.J., Svensson E., Prieto-Alhambra D., Lapi F., Giaquinto C., Picelli G., Boudiaf N., Albers F., et al. Incidence, risk factors and re-exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study. Pediatr. Allergy Immunol. 2020;31:496–505. doi: 10.1111/pai.13237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.13237</ArticleId><ArticleId IdType="pmc">PMC7496431</ArticleId><ArticleId IdType="pubmed">32115766</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreen S., Wilk P., Mullowney T., Karp I. Asthma exacerbation trajectories and their predictors in children with incident asthma. Ann. Allergy Asthma Immunol. 2019;123:293–300.e292. doi: 10.1016/j.anai.2019.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2019.05.013</ArticleId><ArticleId IdType="pubmed">31128235</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2021.  [(accessed on 10 December 2021)].  Available online:  www.ginasthma.org.</Citation></Reference><Reference><Citation>Thomas M., Kay S., Pike J., Williams A., Rosenzweig J.R., Hillyer E.V., Price D. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: Analysis of a multinational cross-sectional survey. Prim. Care Respir. J. 2009;18:41–49. doi: 10.4104/pcrj.2009.00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.4104/pcrj.2009.00010</ArticleId><ArticleId IdType="pmc">PMC6619040</ArticleId><ArticleId IdType="pubmed">19240948</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydin M., Weisser C., Rué O., Mariadassou M., Maaß S., Behrendt A.-K., Jaszczyszyn Y., Heilker T., Spaeth M., Vogel S., et al. The Rhinobiome of Exacerbated Wheezers and Asthmatics: Insights From a German Pediatric Exacerbation Network. Front. Allergy. 2021;2:667562. doi: 10.3389/falgy.2021.667562.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/falgy.2021.667562</ArticleId><ArticleId IdType="pmc">PMC8974812</ArticleId><ArticleId IdType="pubmed">35386977</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber A.L., Everhart K., Daly J.A., Hopper A., Harrington A., Schreckenberger P., McKinley K., Jones M., Holmberg K., Kensinger B. Multicenter Evaluation of BioFire FilmArray Respiratory Panel 2 for Detection of Viruses and Bacteria in Nasopharyngeal Swab Samples. J. Clin. Microbiol. 2018;56:e01945-17. doi: 10.1128/JCM.01945-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01945-17</ArticleId><ArticleId IdType="pmc">PMC5971546</ArticleId><ArticleId IdType="pubmed">29593057</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2020.</Citation></Reference><Reference><Citation>Hadley W., François R., Henry L., Müller K. dplyr: A Grammar of Data Manipulation. R Package Version 1.0.7. 2021.</Citation></Reference><Reference><Citation>David Meyer A.Z., Hornik K. vcd: Visualizing Categorical Data. R Package Version 1.4–9. 2021.</Citation></Reference><Reference><Citation>Wickham H. ggplot2: Elegant Graphics for Data Analysis. Springer; New York, NY, USA: 2016.</Citation></Reference><Reference><Citation>Komlosi Z.I., van de Veen W., Kovacs N., Szucs G., Sokolowska M., O’Mahony L., Akdis M., Akdis C.A. Cellular and molecular mechanisms of allergic asthma. Mol. Aspects Med. 2021:100995. doi: 10.1016/j.mam.2021.100995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2021.100995</ArticleId><ArticleId IdType="pubmed">34364680</ArticleId></ArticleIdList></Reference><Reference><Citation>Mims J.W. Asthma: Definitions and pathophysiology. Int. Forum Allergy Rhinol. 2015;5:S2–S6. doi: 10.1002/alr.21609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.21609</ArticleId><ArticleId IdType="pubmed">26335832</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt P.G. Developmental factors as determinants of risk for infections and atopy in childhood. Eur. Respir. Rev. 2005;14:69–73. doi: 10.1183/09059180.05.00009505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09059180.05.00009505</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez F.D. Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma. Proc. Am. Thorac Soc. 2005;2:157–161. doi: 10.1513/pats.200504-044AW.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/pats.200504-044AW</ArticleId><ArticleId IdType="pubmed">16113485</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholas B., Dudley S., Tariq K., Howarth P., Lunn K., Pink S., Sterk P.J., Adcock I.M., Monk P., Djukanovic R., et al. Susceptibility to influenza virus infection of bronchial biopsies in asthma. J. Allergy Clin. Immunol. 2017;140:309–312.e304. doi: 10.1016/j.jaci.2016.12.964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.12.964</ArticleId><ArticleId IdType="pubmed">28259448</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Kerkhove M.D., Vandemaele K.A., Shinde V., Jaramillo-Gutierrez G., Koukounari A., Donnelly C.A., Carlino L.O., Owen R., Paterson B., Pelletier L., et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: A global pooled analysis. PLoS Med. 2011;8:e1001053. doi: 10.1371/journal.pmed.1001053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001053</ArticleId><ArticleId IdType="pmc">PMC3130021</ArticleId><ArticleId IdType="pubmed">21750667</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.M., Koh H.Y., Moon S.Y., Yoo I.K., Ha E.K., You S., Kim S.Y., Yon D.K., Lee S.W. Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study. J. Allergy Clin. Immunol. 2020;146:790–798. doi: 10.1016/j.jaci.2020.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.08.008</ArticleId><ArticleId IdType="pmc">PMC7428784</ArticleId><ArticleId IdType="pubmed">32810517</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuruvilla M.E., Lee F.E., Lee G.B. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease. Clin. Rev. Allergy Immunol. 2019;56:219–233. doi: 10.1007/s12016-018-8712-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-018-8712-1</ArticleId><ArticleId IdType="pmc">PMC6411459</ArticleId><ArticleId IdType="pubmed">30206782</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabana M.D., McKean M., Caughey A.B., Fong L., Lynch S., Wong A., Leong R., Boushey H.A., Hilton J.F. Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial. Pediatrics. 2017;140 doi: 10.1542/peds.2016-3000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2016-3000</ArticleId><ArticleId IdType="pmc">PMC5574725</ArticleId><ArticleId IdType="pubmed">28784701</ArticleId></ArticleIdList></Reference><Reference><Citation>Forno E., Bacharier L.B., Phipatanakul W., Guilbert T.W., Cabana M.D., Ross K., Covar R., Gern J.E., Rosser F.J., Blatter J., et al. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children with Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial. JAMA. 2020;324:752–760. doi: 10.1001/jama.2020.12384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12384</ArticleId><ArticleId IdType="pmc">PMC7448830</ArticleId><ArticleId IdType="pubmed">32840597</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer F.R., Sicherer S.H., Burks A.W., Committee on Nutrition. Section on Allergy and Immunology The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing of Introduction of Allergenic Complementary Foods. Pediatrics. 2019;143:e20190281. doi: 10.1542/peds.2019-0281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2019-0281</ArticleId><ArticleId IdType="pubmed">30886111</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilbert T.W., Morgan W.J., Krawiec M., Lemanske R.F., Jr., Sorkness C., Szefler S.J., Larsen G., Spahn J.D., Zeiger R.S., Heldt G., et al. The Prevention of Early Asthma in Kids study: Design, rationale and methods for the Childhood Asthma Research and Education network. Control Clin. Trials. 2004;25:286–310. doi: 10.1016/j.cct.2004.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2004.03.002</ArticleId><ArticleId IdType="pubmed">15157730</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrorilli C., Caffarelli C., Hoffmann-Sommergruber K. Food allergy and atopic dermatitis: Prediction, progression, and prevention. Pediatr. Allergy Immunol. 2017;28:831–840. doi: 10.1111/pai.12831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pai.12831</ArticleId><ArticleId IdType="pubmed">29117431</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies-Gow A., Busse W.W., Castro M., Jackson D.J. Prevention and Treatment of Asthma Exacerbations in Adults. J. Allergy Clin. Immunol. Pract. 2021;9:2578–2586. doi: 10.1016/j.jaip.2021.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2021.05.016</ArticleId><ArticleId IdType="pubmed">34246434</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray C.S., Foden P., Sumner H., Shepley E., Custovic A., Simpson A. Preventing Severe Asthma Exacerbations in Children. A Randomized Trial of Mite-Impermeable Bedcovers. Am. J. Respir. Crit. Care Med. 2017;196:150–158. doi: 10.1164/rccm.201609-1966OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201609-1966OC</ArticleId><ArticleId IdType="pubmed">28282501</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson P.J., Cullinan P., Burge S., British Occupational Health Research F. Concise guidance: Diagnosis, management and prevention of occupational asthma. Clin. Med. 2012;12:156–159. doi: 10.7861/clinmedicine.12-2-156.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.12-2-156</ArticleId><ArticleId IdType="pmc">PMC4954103</ArticleId><ArticleId IdType="pubmed">22586793</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachimoto H., Imanari E., Mezawa H., Okuyama M., Urashima T., Hirano D., Gocho N., Urashima M. Effect of Avoiding Cow’s Milk Formula at Birth on Prevention of Asthma or Recurrent Wheeze Among Young Children: Extended Follow-up from the ABC Randomized Clinical Trial. JAMA Netw Open. 2020;3:e2018534. doi: 10.1001/jamanetworkopen.2020.18534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.18534</ArticleId><ArticleId IdType="pmc">PMC7532386</ArticleId><ArticleId IdType="pubmed">33006618</ArticleId></ArticleIdList></Reference><Reference><Citation>Agache I., Beltran J., Akdis C., Akdis M., Canelo-Aybar C., Canonica G.W., Casale T., Chivato T., Corren J., Del Giacco S., et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines—Recommendations on the use of biologicals in severe asthma. Allergy. 2020;75:1023–1042. doi: 10.1111/all.14221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14221</ArticleId><ArticleId IdType="pubmed">32034960</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman K.R., Albers F.C., Chipps B., Munoz X., Devouassoux G., Bergna M., Galkin D., Azmi J., Mouneimne D., Price R.G., et al. The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma. Allergy. 2019;74:1716–1726. doi: 10.1111/all.13850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13850</ArticleId><ArticleId IdType="pmc">PMC6790683</ArticleId><ArticleId IdType="pubmed">31049972</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega H.G., Liu M.C., Pavord I.D., Brusselle G.G., FitzGerald J.M., Chetta A., Humbert M., Katz L.E., Keene O.N., Yancey S.W., et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N. Engl. J. Med. 2014;371:1198–1207. doi: 10.1056/NEJMoa1403290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1403290</ArticleId><ArticleId IdType="pubmed">25199059</ArticleId></ArticleIdList></Reference><Reference><Citation>Soong W., Yoo B., Pazwash H., Holweg C.T.J., Casale T.B. Omalizumab response in patients with asthma by number and type of allergen. Ann. Allergy Asthma Immunol. 2021;127:223–231. doi: 10.1016/j.anai.2021.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2021.04.002</ArticleId><ArticleId IdType="pubmed">33838339</ArticleId></ArticleIdList></Reference><Reference><Citation>Chau-Etchepare F., Hoerger J.L., Kuhn B.T., Zeki A.A., Haczku A., Louie S., Kenyon N.J., Davis C.E., Schivo M. Viruses and non-allergen environmental triggers in asthma. J. Investig. Med. 2019;67:1029–1041. doi: 10.1136/jim-2019-001000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2019-001000</ArticleId><ArticleId IdType="pmc">PMC7428149</ArticleId><ArticleId IdType="pubmed">31352362</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa L.D., Costa P.S., Camargos P.A. Exacerbation of asthma and airway infection: Is the virus the villain? J. Pediatr. 2014;90:542–555. doi: 10.1016/j.jped.2014.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jped.2014.07.001</ArticleId><ArticleId IdType="pmc">PMC7094671</ArticleId><ArticleId IdType="pubmed">25261603</ArticleId></ArticleIdList></Reference><Reference><Citation>Deschildre A., Pichavant M., Engelmann I., Langlois C., Drumez E., Pouessel G., Boileau S., Romero-Cubero D., Decleyre-Badiu I., Dewilde A., et al. Virus-triggered exacerbation in allergic asthmatic children: Neutrophilic airway inflammation and alteration of virus sensors characterize a subgroup of patients. Respir. Res. 2017;18:191. doi: 10.1186/s12931-017-0672-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-017-0672-0</ArticleId><ArticleId IdType="pmc">PMC5686805</ArticleId><ArticleId IdType="pubmed">29137638</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J., Message S.D., Mallia P., Kebadze T., Contoli M., Ward C.K., Barnathan E.S., Mascelli M.A., Kon O.M., Papi A., et al. Bronchial mucosal IFN-alpha/beta and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations. J. Allergy Clin. Immunol. 2019;143:114–125.e114. doi: 10.1016/j.jaci.2018.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.04.003</ArticleId><ArticleId IdType="pmc">PMC6320262</ArticleId><ArticleId IdType="pubmed">29698627</ArticleId></ArticleIdList></Reference><Reference><Citation>Biagi C., Rocca A., Poletti G., Fabi M., Lanari M. Rhinovirus Infection in Children with Acute Bronchiolitis and Its Impact on Recurrent Wheezing and Asthma Development. Microorganisms. 2020;8:1620. doi: 10.3390/microorganisms8101620.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8101620</ArticleId><ArticleId IdType="pmc">PMC7589781</ArticleId><ArticleId IdType="pubmed">33096703</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferolla F.M., Hijano D.R., Acosta P.L., Rodriguez A., Duenas K., Sancilio A., Barboza E., Caria A., Gago G.F., Almeida R.E., et al. Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children. Am. J. Respir. Crit. Care Med. 2013;187:983–990. doi: 10.1164/rccm.201301-0016OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201301-0016OC</ArticleId><ArticleId IdType="pubmed">23449690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy J.L., Pham S., Borish L. Rhinovirus and Asthma Exacerbations. Immunol. Allergy Clin. N. Am. 2019;39:335–344. doi: 10.1016/j.iac.2019.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iac.2019.03.003</ArticleId><ArticleId IdType="pmc">PMC6625523</ArticleId><ArticleId IdType="pubmed">31284924</ArticleId></ArticleIdList></Reference><Reference><Citation>Niespodziana K., Stenberg-Hammar K., Megremis S., Cabauatan C.R., Napora-Wijata K., Vacal P.C., Gallerano D., Lupinek C., Ebner D., Schlederer T., et al. PreDicta chip-based high resolution diagnosis of rhinovirus-induced wheeze. Nat. Commun. 2018;9:2382. doi: 10.1038/s41467-018-04591-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04591-0</ArticleId><ArticleId IdType="pmc">PMC6006174</ArticleId><ArticleId IdType="pubmed">29915220</ArticleId></ArticleIdList></Reference><Reference><Citation>Real-Hohn A., Blaas D. Rhinovirus Inhibitors: Including a New Target, the Viral RNA. Viruses. 2021;13:1784. doi: 10.3390/v13091784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091784</ArticleId><ArticleId IdType="pmc">PMC8473194</ArticleId><ArticleId IdType="pubmed">34578365</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J.W., Loh T.P. Correlations between climate factors and incidence--a contributor to RSV seasonality. Rev. Med. Virol. 2014;24:15–34. doi: 10.1002/rmv.1771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1771</ArticleId><ArticleId IdType="pubmed">24421259</ArticleId></ArticleIdList></Reference><Reference><Citation>Teeratakulpisarn J., Pientong C., Ekalaksananan T., Ruangsiripiyakul H., Uppala R. Rhinovirus infection in children hospitalized with acute bronchiolitis and its impact on subsequent wheezing or asthma: A comparison of etiologies. Asian Pac. J. Allergy Immunol. 2014;32:226–234. doi: 10.12932/AP0417.32.3.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP0417.32.3.2014</ArticleId><ArticleId IdType="pubmed">25268340</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Tong L., Li M., Wang Y., Li L., Yang D., Zhang Y., Chen Z. Recurrent Wheezing and Asthma After Respiratory Syncytial Virus Bronchiolitis. Front. Pediatr. 2021;9:649003. doi: 10.3389/fped.2021.649003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.649003</ArticleId><ArticleId IdType="pmc">PMC8211724</ArticleId><ArticleId IdType="pubmed">34150683</ArticleId></ArticleIdList></Reference><Reference><Citation>Elnifro E.M., Ashshi A.M., Cooper R.J., Klapper P.E. Multiplex PCR: Optimization and application in diagnostic virology. Clin. Microbiol. Rev. 2000;13:559–570. doi: 10.1128/CMR.13.4.559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.13.4.559</ArticleId><ArticleId IdType="pmc">PMC88949</ArticleId><ArticleId IdType="pubmed">11023957</ArticleId></ArticleIdList></Reference><Reference><Citation>Vila J., Gomez M.D., Salavert M., Bosch J. [Methods of rapid diagnosis in clinical microbiology: Clinical needs] Enferm. Infecc. Microbiol. Clin. 2017;35:41–46. doi: 10.1016/j.eimc.2016.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eimc.2016.11.004</ArticleId><ArticleId IdType="pubmed">27993417</ArticleId></ArticleIdList></Reference><Reference><Citation>De Kluijver J., Evertse C.E., Sont J.K., Schrumpf J.A., van Zeijl-van der Ham C.J., Dick C.R., Rabe K.F., Hiemstra P.S., Sterk P.J. Are rhinovirus-induced airway responses in asthma aggravated by chronic allergen exposure? Am. J. Respir. Crit. Care Med. 2003;168:1174–1180. doi: 10.1164/rccm.200212-1520OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200212-1520OC</ArticleId><ArticleId IdType="pubmed">12893645</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Mitlander H., Vuorinen T., Finotto S. Mechanism of Rhinovirus Immunity and Asthma. Front. Immunol. 2021;12:731846. doi: 10.3389/fimmu.2021.731846.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.731846</ArticleId><ArticleId IdType="pmc">PMC8526928</ArticleId><ArticleId IdType="pubmed">34691038</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs S.E., Lamson D.M., St George K., Walsh T.J. Human rhinoviruses. Clin. Microbiol. Rev. 2013;26:135–162. doi: 10.1128/CMR.00077-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00077-12</ArticleId><ArticleId IdType="pmc">PMC3553670</ArticleId><ArticleId IdType="pubmed">23297263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr S.L., Mathew C., Ghildyal R. Rhinovirus and Cell Death. Viruses. 2021;13:629. doi: 10.3390/v13040629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13040629</ArticleId><ArticleId IdType="pmc">PMC8067602</ArticleId><ArticleId IdType="pubmed">33916958</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann M.G., Arnold E., Erickson J.W., Frankenberger E.A., Griffith J.P., Hecht H.J., Johnson J.E., Kamer G., Luo M., Mosser A.G., et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature. 1985;317:145–153. doi: 10.1038/317145a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/317145a0</ArticleId><ArticleId IdType="pubmed">2993920</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnet S., Palmenberg A.C., Gern J.E. Rhinoviruses and Their Receptors. Chest. 2019;155:1018–1025. doi: 10.1016/j.chest.2018.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.12.012</ArticleId><ArticleId IdType="pmc">PMC6533451</ArticleId><ArticleId IdType="pubmed">30659817</ArticleId></ArticleIdList></Reference><Reference><Citation>Schober D., Kronenberger P., Prchla E., Blaas D., Fuchs R. Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms. J. Virol. 1998;72:1354–1364. doi: 10.1128/JVI.72.2.1354-1364.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.2.1354-1364.1998</ArticleId><ArticleId IdType="pmc">PMC124614</ArticleId><ArticleId IdType="pubmed">9445036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewson C.A., Jardine A., Edwards M.R., Laza-Stanca V., Johnston S.L. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J. Virol. 2005;79:12273–12279. doi: 10.1128/JVI.79.19.12273-12279.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.19.12273-12279.2005</ArticleId><ArticleId IdType="pmc">PMC1211516</ArticleId><ArticleId IdType="pubmed">16160153</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K., Vakakis E., Richer E.A., Evans G.L., Villiers J.P., Triantafilou M. Human rhinovirus recognition in non-immune cells is mediated by Toll-like receptors and MDA-5, which trigger a synergetic pro-inflammatory immune response. Virulence. 2011;2:22–29. doi: 10.4161/viru.2.1.13807.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.2.1.13807</ArticleId><ArticleId IdType="pmc">PMC3073236</ArticleId><ArticleId IdType="pubmed">21224721</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa K., Mansbach J.M., Camargo C.A., Jr. Infectious pathogens and bronchiolitis outcomes. Expert Rev. Anti-Infect. Ther. 2014;12:817–828. doi: 10.1586/14787210.2014.906901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14787210.2014.906901</ArticleId><ArticleId IdType="pubmed">24702592</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakaletz L.O. Viral-bacterial co-infections in the respiratory tract. Curr. Opin. Microbiol. 2017;35:30–35. doi: 10.1016/j.mib.2016.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC7108227</ArticleId><ArticleId IdType="pubmed">27940028</ArticleId></ArticleIdList></Reference><Reference><Citation>Lednicky J.A., Rayner J.O. Uncommon respiratory pathogens. Curr. Opin. Pulm. Med. 2006;12:235–239. doi: 10.1097/01.mcp.0000219274.65557.dc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mcp.0000219274.65557.dc</ArticleId><ArticleId IdType="pubmed">16582680</ArticleId></ArticleIdList></Reference><Reference><Citation>Man W.H., de Steenhuijsen Piters W.A., Bogaert D. The microbiota of the respiratory tract: Gatekeeper to respiratory health. Nat. Rev. Microbiol. 2017;15:259–270. doi: 10.1038/nrmicro.2017.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.14</ArticleId><ArticleId IdType="pmc">PMC7097736</ArticleId><ArticleId IdType="pubmed">28316330</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendleton K.M., Huffnagle G.B., Dickson R.P. The significance of Candida in the human respiratory tract: Our evolving understanding. Pathog. Dis. 2017;75:ftx029. doi: 10.1093/femspd/ftx029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femspd/ftx029</ArticleId><ArticleId IdType="pmc">PMC6433300</ArticleId><ArticleId IdType="pubmed">28423168</ArticleId></ArticleIdList></Reference><Reference><Citation>Reckziegel M., Weber-Osel C., Egerer R., Gruhn B., Kubek F., Walther M., Wilhelm S., Zell R., Krumbholz A. Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infection. Eur J. Clin. Microbiol. Infect. Dis. 2020;39:1581–1592. doi: 10.1007/s10096-020-03878-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-03878-9</ArticleId><ArticleId IdType="pmc">PMC7253234</ArticleId><ArticleId IdType="pubmed">32462500</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinwiddie D.L., Denson J.L., Kennedy J.L. Role of the Airway Microbiome in Respiratory Infections and Asthma in Children. Pediatr. Allergy Immunol. Pulmonol. 2018;31:236–240. doi: 10.1089/ped.2018.0958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ped.2018.0958</ArticleId><ArticleId IdType="pmc">PMC6306659</ArticleId><ArticleId IdType="pubmed">30595952</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg G., Rybakova D., Fischer D., Cernava T., Verges M.C., Charles T., Chen X., Cocolin L., Eversole K., Corral G.H., et al. Microbiome definition re-visited: Old concepts and new challenges. Microbiome. 2020;8:103. doi: 10.1186/s40168-020-00875-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-020-00875-0</ArticleId><ArticleId IdType="pmc">PMC7329523</ArticleId><ArticleId IdType="pubmed">32605663</ArticleId></ArticleIdList></Reference><Reference><Citation>David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–563. doi: 10.1038/nature12820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12820</ArticleId><ArticleId IdType="pmc">PMC3957428</ArticleId><ArticleId IdType="pubmed">24336217</ArticleId></ArticleIdList></Reference><Reference><Citation>Depner M., Taft D.H., Kirjavainen P.V., Kalanetra K.M., Karvonen A.M., Peschel S., Schmausser-Hechfellner E., Roduit C., Frei R., Lauener R., et al. Maturation of the gut microbiome during the first year of life contributes to the protective farm effect on childhood asthma. Nat. Med. 2020;26:1766–1775. doi: 10.1038/s41591-020-1095-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1095-x</ArticleId><ArticleId IdType="pubmed">33139948</ArticleId></ArticleIdList></Reference><Reference><Citation>Giles E.M., Couper J. Microbiome in health and disease. J. Paediatr. Child. Health. 2020;56:1735–1738. doi: 10.1111/jpc.14939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.14939</ArticleId><ArticleId IdType="pubmed">32502314</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch S.V., Pedersen O. The Human Intestinal Microbiome in Health and Disease. N. Engl. J. Med. 2016;375:2369–2379. doi: 10.1056/NEJMra1600266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1600266</ArticleId><ArticleId IdType="pubmed">27974040</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Jackson D., Bacharier L.B., Mauger D., Boushey H., Castro M., Durack J., Huang Y., Lemanske R.F., Jr., Storch G.A., et al. The upper-airway microbiota and loss of asthma control among asthmatic children. Nat. Commun. 2019;10:5714. doi: 10.1038/s41467-019-13698-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13698-x</ArticleId><ArticleId IdType="pmc">PMC6915697</ArticleId><ArticleId IdType="pubmed">31844063</ArticleId></ArticleIdList></Reference><Reference><Citation>Durack J., Christian L.S., Nariya S., Gonzalez J., Bhakta N.R., Ansel K.M., Beigelman A., Castro M., Dyer A.M., Israel E., et al. Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma. J. Allergy Clin. Immunol. 2020;146:1016–1026. doi: 10.1016/j.jaci.2020.03.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.03.028</ArticleId><ArticleId IdType="pmc">PMC7554083</ArticleId><ArticleId IdType="pubmed">32298699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai P.S., Kolde R., Franzosa E.A., Gaffin J.M., Baxi S.N., Sheehan W.J., Gold D.R., Gevers D., Xavier R.J., Phipatanakul W. The classroom microbiome and asthma morbidity in children attending 3 inner-city schools. J. Allergy Clin. Immunol. 2018;141:2311–2313. doi: 10.1016/j.jaci.2018.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.02.022</ArticleId><ArticleId IdType="pmc">PMC5994187</ArticleId><ArticleId IdType="pubmed">29518428</ArticleId></ArticleIdList></Reference><Reference><Citation>Phipatanakul W., Bailey A., Hoffman E.B., Sheehan W.J., Lane J.P., Baxi S., Rao D., Permaul P., Gaffin J.M., Rogers C.A., et al. The school inner-city asthma study: Design, methods, and lessons learned. J. Asthma. 2011;48:1007–1014. doi: 10.3109/02770903.2011.624235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/02770903.2011.624235</ArticleId><ArticleId IdType="pmc">PMC3220801</ArticleId><ArticleId IdType="pubmed">22010992</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan A., Hunt E., MacSharry J., Murphy D.M. The Microbiome and the Pathophysiology of Asthma. Respir. Res. 2016;17:163. doi: 10.1186/s12931-016-0479-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-016-0479-4</ArticleId><ArticleId IdType="pmc">PMC5139145</ArticleId><ArticleId IdType="pubmed">27919249</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch A., Levin E., van Houten M.A., Hasrat R., Kalkman G., Biesbroek G., de Steenhuijsen Piters W.A.A., de Groot P.C.M., Pernet P., Keijser B.J.F., et al. Development of Upper Respiratory Tract Microbiota in Infancy is Affected by Mode of Delivery. EBioMedicine. 2016;9:336–345. doi: 10.1016/j.ebiom.2016.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2016.05.031</ArticleId><ArticleId IdType="pmc">PMC4972531</ArticleId><ArticleId IdType="pubmed">27333043</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohajeri M.H., Brummer R.J.M., Rastall R.A., Weersma R.K., Harmsen H.J.M., Faas M., Eggersdorfer M. The role of the microbiome for human health: From basic science to clinical applications. Eur. J. Nutr. 2018;57:1–14. doi: 10.1007/s00394-018-1703-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-018-1703-4</ArticleId><ArticleId IdType="pmc">PMC5962619</ArticleId><ArticleId IdType="pubmed">29748817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloepfer K.M., Lee W.M., Pappas T.E., Kang T.J., Vrtis R.F., Evans M.D., Gangnon R.E., Bochkov Y.A., Jackson D.J., Lemanske R.F., Jr., et al. Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations. J. Allergy Clin. Immunol. 2014;133:1301–1307. doi: 10.1016/j.jaci.2014.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2014.02.030</ArticleId><ArticleId IdType="pmc">PMC4047978</ArticleId><ArticleId IdType="pubmed">24698319</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo S.M., Mok D., Pham K., Kusel M., Serralha M., Troy N., Holt B.J., Hales B.J., Walker M.L., Hollams E., et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015;17:704–715. doi: 10.1016/j.chom.2015.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2015.03.008</ArticleId><ArticleId IdType="pmc">PMC4433433</ArticleId><ArticleId IdType="pubmed">25865368</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansbach J.M., Hasegawa K., Henke D.M., Ajami N.J., Petrosino J.F., Shaw C.A., Piedra P.A., Sullivan A.F., Espinola J.A., Camargo C.A., Jr. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J. Allergy Clin. Immunol. 2016;137:1909–1913.e1904. doi: 10.1016/j.jaci.2016.01.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.01.036</ArticleId><ArticleId IdType="pmc">PMC4899255</ArticleId><ArticleId IdType="pubmed">27061249</ArticleId></ArticleIdList></Reference><Reference><Citation>Amat F., Plantard C., Mulliez A., Petit I., Rochette E., Verdan M., Henquell C., Labbe G., Heraud M.C., Evrard B., et al. RSV-hRV co-infection is a risk factor for recurrent bronchial obstruction and early sensitization 3 years after bronchiolitis. J. Med. Virol. 2018;90:867–872. doi: 10.1002/jmv.25037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25037</ArticleId><ArticleId IdType="pmc">PMC7167020</ArticleId><ArticleId IdType="pubmed">29380391</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosas-Salazar C., Shilts M.H., Tovchigrechko A., Schobel S., Chappell J.D., Larkin E.K., Shankar J., Yooseph S., Nelson K.E., Halpin R.A., et al. Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection with Human Rhinovirus and Respiratory Syncytial Virus in Infancy. J. Infect. Dis. 2016;214:1924–1928. doi: 10.1093/infdis/jiw456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw456</ArticleId><ArticleId IdType="pmc">PMC5142087</ArticleId><ArticleId IdType="pubmed">27923952</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>